Literature DB >> 8822385

Clozapine therapy in patients with neurologic illness.

M Sajatovic1, L Ramirez.   

Abstract

OBJECTIVE: This review will analyze the use of clozapine in patients with neurologic illness.
METHODS: A review of the literature was performed. Attention is focused particularly on patients with seizure disorder, head injury, mental retardation, Parkinson's disease, Huntington's disease, tardive dyskinesia, and selected other neurological disorders.
RESULTS: This review discusses clinical difficulties/issues associated with clozapine therapy in patients with a variety of neurological disorders.
CONCLUSION: Although clozapine therapy should be reserved for those patients who are refractory to conventional psychotropic medications, when used appropriately it may offer a safe and effective way of improving quality of life for patients with behavioral symptoms and neurologic illness.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8822385     DOI: 10.2190/4EC8-H122-HJAL-YDLV

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  4 in total

1.  Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation.

Authors:  R Hammock; W R Levine; S R Schroeder
Journal:  J Autism Dev Disord       Date:  2001-02

2.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 3.  Clozapine for psychotic disorders in adults with intellectual disabilities.

Authors:  Muhammad Ayub; Khalid Saeed; Tariq A Munshi; Farooq Naeem
Journal:  Cochrane Database Syst Rev       Date:  2015-09-23

4.  The geriatric population and psychiatric medication.

Authors:  Sannidhya Varma; Himanshu Sareen; J K Trivedi
Journal:  Mens Sana Monogr       Date:  2010-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.